{
    "clinical_study": {
        "@rank": "122630", 
        "arm_group": {
            "arm_group_label": "Methylene Blue", 
            "arm_group_type": "Experimental", 
            "description": "1% Methylene Blue - 1 ml. Methylene blue dye injection of sentinel lymph node"
        }, 
        "brief_summary": {
            "textblock": "The investigators plan to study the ability to identify the lymph nodes beyond the sentinel\n      lymph node that may harbor cancer using methylene blue dye."
        }, 
        "brief_title": "Second Echelon Node Study With Methylene Blue", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Breast Cancer", 
            "Melanoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Melanoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed primary cutaneous melanoma located on the extremity or trunk\n\n          -  Patients with clinically stage I-II melanoma\n\n          -  Histologically confirmed invasive ductal or lobular carcinoma\n\n          -  Patient undergoing surgical treatment of breast primary and sentinel lymph node\n             biopsy- clinically node negative\n\n        Exclusion Criteria:\n\n          -  Melanoma located on the head or neck, uveal or mucosal\n\n          -  Previous surgery or radiation in or near the sentinel lymph node bopsy nodal basin\n\n          -  Preoperative biopsy proven regional lymph node involvement\n\n          -  Failure of lymphatic mapping with radioactive colloid\n\n          -  Women who are pregnant or nursing\n\n          -  Prior ipsilateral axillary surgery or radiation\n\n          -  Inflammatory breast cancer\n\n          -  No lymph node identified in the ipsilateral breast during pathologic review of the\n             mastectomy specimen\n\n          -  Stage IV breast cancer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823172", 
            "org_study_id": "12-009929"
        }, 
        "intervention": {
            "arm_group_label": "Methylene Blue", 
            "intervention_name": "Methylene blue dye injection of sentinel lymph node", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Methylene Blue"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "breast cancer", 
            "melanoma", 
            "sentinel lymph node biopsy", 
            "lymphadenectomy"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "James Jakub, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The number of subjects in whom a secondary echelon lymph node is identified", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823172"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "James W. Jakub", 
            "investigator_title": "Breast and Melanoma Surgery Section Head", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}